The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 2×
“Two families of innate immune receptors, the Tolllike receptors (TLRs) and the nu cleotidebinding domain, leucinerichrepeat containing (NLR) proteins, have emerged as essential mediators of gastrointestinal inflam mation and homeostasis (Akira et al., 2006; Franchi et al., 2006).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 4×
“How ever, damage to the colonic epithelial cell layer in the colon initiates the release of various DAMP signals, and DAMPs have the potential to activate the NLRP3 inflam masome.”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 6×
“Jenny P.-Y. Ting: panyun@med.unc.edu Abbreviations used: AOM, azoxymethane; ASC/ PYCARD, Apoptotic Speck protein containing a CARD; CAC, colitisassociated cancer; CRC, colorectal cancer; DAMP, damageassociated molecular pattern; DSS, dextran sulfate sodium; HAI, Histologi cal Activity Index; IBD, inflam matory bowel d…”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“AIM2 has been shown to form of commensal normal flora in the intestine (RakoffNahoum et al., 2004; Araki et al., 2005; Fukata et al., 2005).”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“Patients suffering from UC demonstrate a significantly increased risk of colorectal cancer (CRC), which seems to be associated with both the duration of the disease and the degree of mucosal inflammation (Eaden et al., 2001).”
BackgroundAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 16×
“Organ culture supernatants were harvested after incubation for 24 h and IL1, IL18, and TNF levels were determined by ELISA.”
InfluentialIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 2×
“…functional Nlrp3, Nlrc4, Pycard, and caspase1 (Casp1) has been previously described (R. Flavell, Yale University, New Haven, CT; V. Dixit, Genentech, Inc., San Francisco, CA; F. Sutterwala, University of Iowa, Iowa City, IA; Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al., 2006).”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839 · cited 5×
“In ad dition to NLRP3, other NLRs, such as NLRC4, can form NLRP3independent inflammasome in response to specific stimuli, such as flagellin (Mariathasan et al., 2004).”
BackgroundInfluential
Cited by
Items 601–700 of 849
Prossomariti, A., Sokol, H., & Ricciardiello, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01039 · Cited by 13
“showed a critical disease outcome and increased tumor burden in the same Casp1−/− and Asc−/− mice in the DSS and azoxymethane (AOM)-DSS models of colitis and CAC (28).”
BackgroundNLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
Liu, L., & Li, X. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4650-7 · Cited by 12
Interleukin-1β: Friend or foe for gastrointestinal cancers
Khawkhiaw, K., Panaampon, J., Imemkamon, T., & Saengboonmee, C. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i5.1676 · Cited by 13
“Increased tumor burden was correlated with attenuated levels of IL-1 β and IL-18 at the tumor sites[28].”
Stergiou, I. Ε., Tsironis, C., Papadakos, S. P., Tsitsilonis, O., Dimopoulos, M. A., & Theocharis, S. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042369 · Cited by 11
Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome
Far, N. P., Varnousafaderani, M. H., Faghihkhorasani, F., Etemad, S., Abdulwahid, A. R. R., Bakhtiarinia, N., Mousaei, A., Dortaj, E., Karimi, S., Ebrahimi, N., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17352 · Cited by 13
“Its downregulation is associated with more morbidity and weak prognosis in patients (Allen et al., 2010) Lymphoma Tumour progression Promoting anti-apoptotic actors and lymphoma cell proliferation, inhibiting pro-apoptotic factors (Zhao et al., 2017) Colorectal cancer (CRC)”
Lack of reelin modifies the gene expression in the small intestine of mice
García‐Miranda, P., Vázquez‐Carretero, M. D., Gutiérrez, G., Rubio, M. J. P., & Ilundáin, A. A. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0132-0 · Cited by 11
Long, X., Yu, X., Gong, P., Wang, X., & Tian, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.780179 · Cited by 11
“Although the role of the NLRP3 inflammasome in murine IBD models with NLRP3, ASC, or caspase-1 deficiency remains controversial (Siegmund et al., 2001; Allen et al., 2010; Bauer et al., 2010; Dupaul-Chicoine et al., 2010; Zaki et al., 2010; Bauer et al., 2012; Mao et al., 2018), inhibitors targeting the NLRP3 inflamma…”
BackgroundRab GTPase Mediating Regulation of NALP3 in Colorectal Cancer
Tezcan, G., Garanina, E. E., Zhuravleva, M. N., Hamza, S., Rizvanov, A. A., & Khaiboullina, S. F. (2020) · Molecules · doi:10.3390/molecules25204834 · Cited by 11
“However, several studies have also reported the effects of the low levels of the NALP3 inflammasome function on CRC development [17,18], which suggests that NALP3 inflammasome plays a balancing role in the regulation of inflammation [11].”
BackgroundA novel identified pyroptosis-related prognostic signature of colorectal cancer
Chen, Z., & Tan, Z. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021433 · Cited by 12
Jiang, R., Wang, T., Lan, Q., Qin, Y.-C., Man, T.-T., Sun, H., Li, Z.-L., Zhong, X.-T., Mo, C.-M., & Rong, Z. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02543-9 · Cited by 11
The diagnostic and prognostic role of cytokines in colon cancer
Raufman, J., & Long (2011) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s18423 · Cited by 14
“20 Compared to wild-type (WT) controls, mice lacking the inflammasome adaptor protein ASC/PYCARD or caspase-1 that were treated with dextran sulfate sodium (DSS) and azoxymethane (AOM) had increased disease severity and tumor burden.”
BackgroundInflammatory bowel disease: recent advances on genetics and innate immunity.
Karantanos, T., & Gazouli, M. (2011) · PubMed Central · Cited by 21
Song, M., Zhu, X., Zhao, X., Feng, J., & Sui, X. (2026) · Plants · doi:10.3390/plants15040575 · Cited by 16
“However, other studies have indicated that NLRP3-deficient mice exhibit a higher tumor burden, as it regulates the production of IL-1/IL-18 through hematopoietic cells to exert anti-tumor effects [73].”
Mechanism of inflammasomes in cancer and targeted therapies
Gu, Q., Zou, J., Zhou, Y. Y., & Deng, Q. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1133013 · Cited by 12
“However, this aspect of research is still controversial: some studies have shown a positive correlation between NLRP3 inflammasomes and CRC, but a part of the research holds the opposite view, they suggest that NLRP3 inflammasomes may inhibit tumor development (65).”
ResultInnate Immune Stimulation in Cancer Therapy
Duewell, P., Heidegger, S. M., & Kobold, S. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.12.002 · Cited by 12
Somatic Mutation of NLRP Genes in Gastric and Colonic Cancers
Moon, S. W., Son, H. J., Mo, H. Y., Yoo, N. J., & Lee, S. H. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.607385 · Cited by 10
“For example, recent studies identified NLRPs that modulated the mucosal immune response during inflammatory bowel diseaseassociated tumorigenesis [8, 9].”
ResultTsolaki, A. G., Varghese, P. M., & Kishore, U. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-67452-6_9 · Cited by 13
Nguyen, T.-K., Kumar, R. P., & Park, P. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01437-2 · Cited by 11
“Dysregulation of inflammasomes is linked with various inflammationassociated diseases, including inflammatory bowel disease (Allen et al. 2010; Bauer et al. 2010), arthritis (Joosten et al.”
BackgroundThe NLRC4 inflammasome: The pieces of the puzzle are falling into place
Hafner‐Bratkovič, I. (2017) · Inflammasome · doi:10.1515/infl-2017-0002 · Cited by 11
Baliou, S., Adamaki, M., Spandidos, D. A., Kyriakopoulos, A. M., Christodoulou, I., & Zoumpourlis, V. C. (2018) · World Academy of Sciences Journal · doi:10.3892/wasj.2018.6 · Cited by 11
Sun, Z., LV, J., Zhu, Y., SONG, D., ZHU, B., & Miao, C. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2335 · Cited by 11
“The Nod-like receptor (NLR) family contributes either directly or indirectly to a variety of hallmarks associated with cancer, including inflammation, cell death, tumor growth, angiogenesis, invasion and metastasis (30-34).”
Pyroptosis: Turning Up the Heat on Cancer
Zhang, Z., & Lieberman, J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-041848 · Cited by 10
The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases
Wang, Y., Liu, X., Xia, P., Li, Z., FuChen, X., Shen, Y., Yu, P., & Zhang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901166 · Cited by 11
“Damage-Associated Molecular Patterns: DAMPs trigger chronic immune responses that alter tissue function, produced and detected by TLRs or NLRs on innate immune cells (77).”
BackgroundLi, X., Wang, Z., Gao, H., Xiao, Y., Li, M., Huang, Y., Liu, G., Guo, Y., Song, L., & Ren, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21869 · Cited by 14
“…decoction, and L -Fucose alleviated DSS-induced colitis via inhibiting activation of Nlrp3 inflammasome [48 – 50], while Nlrp3( (cid:0) / (cid:0) ) mice showed an increase in acute and recurring colitis, which implies that the Nlrp3 inflammasome may function as a negative regulator in colitis [51].”
BackgroundLang, W., Wen, X., Zhang, S., Liang, X., Chen, L., Zhang, D., Zhou, R., Ali, I., Hu, X., Zhang, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405084 · Cited by 9
Inflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling
Műzes, G., & Sípos, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116167 · Cited by 9
“A severe enhancement in acute and recurrent colitis as well as the progression of CAC was observed in rodents lacking NLRP3, Pycard, and Casp-1, which was partially induced by suppressed IL1 and IL18 [19].”
BackgroundRutkowski, M. R., & Conejo-Garcia, J. R. (2015) · Oncoscience · doi:10.18632/oncoscience.145 · Cited by 12
“com/oncoscience the inflammasome, including Nlrp6, Nlrp3 and Capase-1 cause dysbiosis and intestinal inflammation in some facilities [27-29].”
BackgroundMouse Models of Allergic Disease
Allen, I. C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-496-8 · Cited by 9
Self-citationDerivation of Macrophages from Mouse Bone Marrow
Davis, B. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9167-9_3 · Cited by 9
An Overview of the Involvement of Interleukin-18 in Degenerative Retinopathies
Campbell, M., Doyle, S., Ozaki, E., Kenna, P. F., Kiang, A., Humphries, M. M., & Humphries, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_52 · Cited by 9
Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis
Singh, N., Inoue, M., Osawa, R., Wagener, M. M., & Shinohara, M. L. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.05.012 · Cited by 9
“Once the tumor becomes established, these create a local milieu conducive for tumor growth, angiogenesis, and metastasis [39].”
Ma, Z., Zhang, J., Li, Z., Zhu, Y., Han, X., Lei, L., Cheng, K., & Liu, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073287 · Cited by 8
“IL-1 β has been shown to play a protective role in chemically induced colon cancer mouse models [35].”
The role of NLRP3 inflammasome in digestive system malignancy
Sun, C.-C., Li, L., Tao, H., Jiang, Z.-C., Wang, L., & Wang, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1051612 · Cited by 8
“proliferation during colitis remission; NLRP3 deficient mice were found to be more susceptible to dextran sodium sulfate (DSS) and 2,4,6-trinitrobenzenesulfonic acid, and showed more sever colonic inflammation, and higher carcinogenesis (Allen et al., 2010; Zaki et al., 2010; Zaki et al., 2011).”
BackgroundTsolakos, N., Haswell, L. E., Miazzi, F., Bishop, E., Antoranz, A., Pliaka, V., Minia, A., Alexopoulos, L. G., Gaça, M., & Breheny, D. (2024) · Toxicology Reports · doi:10.1016/j.toxrep.2024.04.006 · Cited by 9
“Moreover, it should be noted that, while studies have shown that IL-1 β accumulation has pro-tumorigenic and pro-inflammatory roles in most cells, IL-1 β has also shown an antagonistic effect on tumor growth and has shown tumor inhibiting effects [2, 21].”
BackgroundIliaz, R., Akyüz, Ü., Tekin, D., Serilmez, M., Evirgen, S., Çavuş, B., Oğuz, H., Duranyıldız, D., Karaca, Ç., Demır, K., et al. (2016) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2016.10.002 · Cited by 8
NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development
Filippo, M. D., Hennig, P., Karakaya, T., Slaufova, M., & Beer, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012308 · Cited by 10
“In DSS (dextran sulfate sodium)- and AOM (azoxymethane)-induced colitis models, ablation of NLRP3 expression increases the number of intestinal tumors [25,26,97].”
BackgroundTummala, P., Rooke, M., Dahlstrom, J. E., Takahashi, S., Casarotto, M. G., Fernando, N., Hughes, M. M., O'Neill, L. A. J., & Philip G. Board (2021) · Carcinogenesis · doi:10.1093/carcin/bgab008 · Cited by 8
Modak, M., & Singh, S. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09655-y · Cited by 8
“Chronic mucosal damage is caused by ensuring pyroptosis, IL-18, IL-1β, which intensify the breakdown of epithelial barrier and neutrophil recruitment [75].”
Lei, Y. L., Lui, V. W. Y., Grandis, J. R., & Egloff, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085619 · Cited by 7
“A variety of NLR-mediated signaling pathways convey meticulous regulatory mechanisms in cell death [11], inflammation [9,10,12], autophagy [13–16], and more recently carcinogenesis [17–24].”
BackgroundShimane, T., Kobayashi, H., Takeoka, M., Kitazawa, M., Matsumura, T., Hida, S., Xiao, T., Koike, T., Taniguchi, S., & Kurita, H. (2013) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2013.03.013 · Cited by 9
Negative prognostic impact of tumor deposits in stage III colorectal cancer patients
Ma, T., Qin, Z., Xu, G., Zheng, P., Feng, L.-H., Ma, D.-N., Fu, Z., & Gao, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310327 · Cited by 8
“Previous studies have shown that NLRP3 deficiency is associated with a significantly increased incidence of colitis and colorectal cancer induced by the DNA-damaging agent azomethane (AOM) and the chemical colitogenic dextran sulfate sodium (DSS) in mouse models [40,41].”
BackgroundNLRP3 and Gut–Liver Axis: New Possibility for the Treatment of Alcohol‐Associated Liver Disease
Dong, L., Zhang, H., Kang, Y., Wang, F., Bai, T., & Yang, Y. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16935 · Cited by 7
Inflammasomes in the Gut Mucosal Homeostasis
Yao, X., & Meng, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_6 · Cited by 8
“In the animal model study, initially, there were two reports showing that NLRP3 played a protective role in the DSS-induced colitis, as Nlrp3 mice were more susceptible to DSS challenge [56, 65].”
BackgroundResultInfluentialGhanavat, M., Arjmand, B., & Rahim, F. (2022) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-022-00805-3 · Cited by 10
“, Nlrp3, Caspase-1, and pro-inflammatory cytokines such as IL-18 and IL-1β, were more susceptible to CRC [19, 24, 30, 31].”
BackgroundExpression of Inflammasome-Associated Proteins in Human Oropharyngeal Squamous Cell Carcinoma
Takano, K., Kondo, A., Kurose, M., Yamashita, K., Nomura, K., Obata, K., Murayama, K., Ito, F., & Himi, T. (2016) · Advances in oto-rhino-laryngology · doi:10.1159/000441884 · Cited by 10
Schistosoma mansoni soluble egg antigen suppresses colorectal cancer growth in vitro and in vivo
Lam, H. Y. P., Liang, T.-R., Jiang, S., & Peng, S.-Y. (2024) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2024.11.009 · Cited by 7
Bacteria-assisted metal antitumor immunotherapy
Guo, J., Liang, J., Chen, Z., Pan, Y., He, Y., & Chao, H. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216938 · Cited by 6
Chong, Y., Chang, H., Li, J., & Long, X. (2020) · Journal of International Medical Research · doi:10.1177/0300060520965824 · Cited by 7
Pan, S., Chen, L., Song, C., Fan, T. T., Hao, B., Zhang, L., Li, D., & Geng, Q. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110355 · Cited by 6
Immunologic Repercussions of Cell Death
Beere, H. M., & Green, D. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00028-0 · Cited by 6
Li, H., Chang, X., Wang, H., Peng, B., Wang, J., Zhang, P., & Zhang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.934835 · Cited by 6
“One study showed an anti-tumor effect in colon cancer, while another study showed that NLRC4 had no effect on cancer progression (32, 33).”
Zhou, Q. H., Guo, Y., Tian, Z., Qiu, Y., Liu, Y., Liu, Q., Liu, Y., Yang, Y., Shi, L., Li, X., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167352 · Cited by 6
Deng, T., Cui, J., Lyon, C. J., Zhang, N., Wang, H. Y., Wang, R., & Hsueh, W. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_2 · Cited by 5
IL-1 Superfamily and Inflammasome
Dinarello, C. A. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch20 · Cited by 6
Molecular mechanisms of cell death
Shanmugam, M. K., & Sethi, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814208-0.00002-6 · Cited by 7
Mizote, Y., Wakamatsu, K., Ito, S., Uenaka, A., Ohue, Y., Kurose, K., Isobe, M., Itô, A., Tamura, Y., Honda, H., et al. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.11.006 · Cited by 6
Vanhove, W., Peeters, P. M., Cleynen, I., Assche, G. V., Ferrante, M., Vermeire, S., & Arijs, I. (2017) · Inflammasome · doi:10.1515/infl-2017-0001 · Cited by 6
Compton, S. R., Booth, C. J., & Macy, J. D. (2017) · PubMed Central · Cited by 5
Implications of Inflammasomes in Human Diseases: NLRP3 Inflammasome and Animal Models
Sakimoto, T. (2018) · Cornea · doi:10.1097/ico.0000000000001717 · Cited by 6
Zhang, Q., Lai, Z., Nian, W., Wang, H., & Tao, J. (2025) · Molecular & Cellular Toxicology · doi:10.1007/s13273-025-00538-x · Cited by 4
“Activation of NLRP3 inflammatory vesicles leads to self-activation of caspase-1, and activated caspase-1 promotes the maturation and secretion of inflammatory mediators IL-18 and IL-1β, which in turn initiate a series of inflammatory responses (Allen et al. 2010).”
Barendrecht, A., Peeters, H. H. C., Torres‐García, D., Shema, M. T., Sarris, A. J. C., David, S. T., Aba, G., Gall, C. M. L., Wilkovitsch, M., Verdoes, M., et al. (2025) · RSC Chemical Biology · doi:10.1039/d5cb00113g · Cited by 4
Gut Microbial Influence and Probiotics on Colorectal Cancer
Myung, D., & Joo, Y. (2012) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2012.60.5.275 · Cited by 6
Focused ultrasound restrains the growth of orthotopic colon cancer via promoting pyroptosis
Mo, W., Yu, Q., Kuang, X., He, T., Lou, J. Q., Tang, R., Zhang, K., Li, L.-D., & Zhao, L. (2023) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2023.0003 · Cited by 4
Cuello, H., Sinha, S., Verhagen, A., Varki, N. M., Varki, A. P., & Ghosh, P. (2024) · JCI Insight · doi:10.1172/jci.insight.181539 · Cited by 6
“%) and 14 days of recovery, as described previously (28).”
BackgroundMethodHirota, S. A., Ueno, A., Tulk, S. E., Becker, H. M., Schenck, L. P., Potentier, M. S., Li, Y., Ghosh, S. K., Muruve, D. A., MacDonald, J. A., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/5637685 · Cited by 5
“They reported that both WT and Nlrp3−/− mice receiving Nlrp3−/− bone marrow exhibited enhanced weight loss, increased severity of disease, and elevated histological assessment scores, compared to WT recipient mice [8].”
BackgroundResultMucosal Bacterial Recognition and Signaling Systems in the Intestine
Fukata, M., & Abreu, M. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00041-5 · Cited by 9
PYCARD (PYD and CARD domain containing)
Dunn, J., & Fujita, M. (2015) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/56440 · Cited by 4
“2015; 19(4) 294 NLRP3/ASC-dependent caspase-1 activity is critical for IL-18-mediated IFN-γ-dependent STAT1 tumor suppression of colorectal cancer triggered by chronic inflammation (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Zaki et al., 2010).”
Arnold, C. M., Kienes, I., Sowa, A. S., & Kufer, T. A. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0026236 · Cited by 5
Wan, C., Xu, Y., Zhu, Y., Cao, X., Wang, P., & Gu, Y. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13550 · Cited by 3
“NLRP3 is a potent tumor suppressor in colitis‑induced colorectal cancer, effectively inhibiting liver metastasis by increasing the anticancer activity of natural killer (NK) cells (15,16).”
Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies
Ouyang, D., Chen, R., Xie, H., Yang, X., Li, Q., & Chen, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.007 · Cited by 3
The Roles of Interleukin-18 in Inflammation and Autoimmune Disease
Zhao, Y., Tang, Y. Y., Zhu, X., Hou, Y., Li, H., Ciccia, F., Zou, H., & Lu, L. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-026-09139-5 · Cited by 3
Wang, J., Luo, A., Yao, Y., Liu, A., & Zhu, X. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114987 · Cited by 4
Research and development prospects of TRIM65
Deng, N.-H., Chen, J.-H., Tian, Z., & Quan, S.-B. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06285-9 · Cited by 3
“The NLRP3 Inflammasome plays a dual role in tumors: it can inhibit colitis-related colorectal cancer(Allen et al. 2010 ; Zaki et al. 2010 ), and also promote NSCLC(Sorrentino et al. 2015 ), gastric cancer(Castaño-Rodríguez et al. 2014 ), pancreatic cancer(Miskiewicz et al. 2015 ), and…”
Inflammasome activation in the gut
Leavy, O. (2010) · Nature reviews. Immunology · doi:10.1038/nri2776 · Cited by 3
Innate Immune Pattern Recognition and the Development of Intestinal Cancer
Siegel, S. J., & Rakoff-Nahoum, S. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_14 · Cited by 3
Inflammasomes in Myeloid Cells: Warriors Within
Jha, S., Brickey, W. J., & Ting, J. P.-Y. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch17 · Cited by 4
Self-citationPlitt, T., & Faith, J. J. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101735 · Cited by 3
Altered insulin sensitivity and immune function in patients with colorectal cancer
Baban, B., Eklund, D., Tuerxun, K., Alshamari, M., Laviano, A., Ljungqvist, O. H., & Särndahl, E. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.09.917 · Cited by 3
Recent updates on pyroptosis in tumors of the digestive tract
Wang, R. H., Shang, B. B., Wu, S. X., Wang, L., & Sui, S. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13244 · Cited by 3
“57 This indicates that NLRP3 can hinder tumorigenesis.”
BackgroundMobiliser l’immunité innée dans le traitement des cancers
Garaude, J. (2013) · médecine/sciences · doi:10.1051/medsci/20132911014 · Cited by 4
“Néanmoins, la capacité qu’ont certaines drogues anticancéreuses de stimuler un inflammasome dépendant de NLRP3 et semble également pouvoir participer à la mobilisation de cellules myéloïdes promotrices de tumeurs [21].”
BackgroundInfluentialThe Microbiota: A New Player in the Etiology of Colorectal Cancer
Levy, M., Thaiss, C. A., & Elinav, E. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-013-0196-z · Cited by 3
Anthony, K. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2862 · Cited by 3
Best Practice & Research Clinical
Savic, S., Dickie, L. J., Wittmann, M., & McDermott, M. (2012) · Cited by 3
Molecular mechanisms of intestinal inflammation leading to colorectal cancer
Shastri, S., Vemuri, R., Gueven, N., Shastri, M. D., & Eri, R. D. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.1.152 · Cited by 4
“However, dampened production of NOD/NLRPs in mouse model of IBD-CRC has shown to increase IBD severity and rapid progression towards tumor development [108,109,110].”
Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy
Luo, J., Zhang, Q., Wang, S., Zheng, L., Liu, J., Zhang, Y., Wang, Y., Wang, R., Xiao, Z., & Li, Z. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096281451240306062101 · Cited by 2
Wen, X., Cui, M., Zhang, J., & Huang, H. J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02982-6 · Cited by 2
Momeni, H. S., Tabibzadeh, S., & Niapour, A. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70793 · Cited by 2
Zhang, Z., Li, Y., Lv, Z., & Man, S. M. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169829 · Cited by 3
Boaru, D. L., Castro-Martinez, P. D., García-Montero, C., Fraile‐Μartinez, O., Alhaddadin, M. N. M., Barrena-Blázquez, S., López-González, L., Tasende, C., Hurtado, R. A., Giménez, T. R., et al. (2026) · MedComm · doi:10.1002/mco2.70844 · Cited by 2
Liu, S., Liu, X., Hu, J., Chen, H., Yang, S., Feng, J., & Sui, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08574-4 · Cited by 2
“In experimental models, NLRP3 deficiency is associated with more severe colitis, increased mortality, greater histopathological damage, enhanced bacterial translocation, and delayed mucosal healing, supporting an overall protective role for basal NLRP3 signaling in the intestine [57, 58].”
Double-Stranded RNA Dependent Kinase R Regulates Antibacterial Immunity in Sepsis
Yang, Y., Xie, L., Zhong, Y., Zhong, X., Meng, R., Xue, Q., Liang, F., Zhao, K., & Tang, Y. (2020) · Journal of Innate Immunity · doi:10.1159/000507932 · Cited by 2
Chronic Obstructive Pulmonary Disease COPD and lung cancer: is the inflammasome at the cross-talk?
Colarusso, C. (2022) · doi:10.36118/pharmadvances.2021.25 · Cited by 2
“Although Casp1-/-Casp11129mt/129mt mice showed enhanced tumorigenesis during colitis-associated cancer development (16-18), the absence of caspase-1/-11 signifi cantly reduced the establishment of lung adenocarcinoma (9, 12).”
BackgroundKey Factors Regulating the Interdomain Dynamics May Contribute to the Assembly of ASC
Li, T., Pineda, L. I. G., Stevens, A. O., & He, Y. J. (2023) · Biology · doi:10.3390/biology12060796 · Cited by 2
Inflammatory caspase-1, -4, and -5 and their role in anticancer activity
Shakya, R., Navneesh, Pandey, S., Pasricha, S., Kurmi, B. D., & Patel, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15644-1.00003-1 · Cited by 2
Pantić, I., Lugonja, S., Jerotić, D., Pljesa-Ercegovac, M. S., Matic, M. G., Bakovic, N., Vojnović, M., Simic, T. P., Milovanovic, T., & Savic-Radojevic, A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020488 · Cited by 2
“…and host defense, proposed protective roles of inflammasome activation also include the regulation of cell proliferation and apoptosis, tissue repair, the synthesis of antimicrobial peptides [39], the prevention of tumor development [40] and the regulation of NF-κ B and MAPK signaling [41].”
Liu, S., & Zhang, J. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70035 · Cited by 5
Microbial Sensing and Regulation of Mucosal Immune Responses by Intestinal Epithelial Cells
Rescigno, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00028-8 · Cited by 2
Immunology and Immunotherapy of Colorectal Cancer
Varela‐Calviño, R., & Cordero, O. J. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_11 · Cited by 2
Inflammasomes and Mucosal Immune Response
Elinav, E., Henao‐Mejia, J., & Flavell, R. A. (2013) · Else Kröner-Fresenius Symposia · doi:10.1159/000346510 · Cited by 2
Inflammasomes and Inflammation
Chen, K. W., Richards, A. A., Zamoshnikova, A., & Schroder, K. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch8 · Cited by 2
Metadata
- Authors
- Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center 1 , 2 , 3 , 4 , 5 , 6 , 7
- Corresponding author
- Ting, Jenny P.-Y.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-12
- Volume
- 207
- Issue
- 5
- Pages
- 1045-1056
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2867287
- OpenAlex
- W2058590329
- Cited by
- 826
- References
- 44
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 54 · 2023: 54 · 2022: 66 · 2021: 53 · 2020: 43 · 2019: 55 · 2018: 54 · 2017: 61 · 2016: 45 · 2015: 56 · 2014: 51 · 2013: 62 · 2012: 49
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (2t32ar007416-25)
- National Cancer Institute (T32CA009156)
- National Institute of Allergy and Infectious Diseases (F32AI082895, U19AI077437, U19-AI077437-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338, P30‐DK34987, P30DK034987)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32-AR007416)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD046369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, colitis-associated colorectal cancer, inflammatory bowel disease, carcinogenesis, caspase-1, IL-1β, IL-18, NLRP3 knockout mice, NLRC4, hematopoietic cells, bone marrow reconstitution, DSS-induced colitis, azoxymethane, intestinal polyps
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Colitis, Colon, Cytoskeletal Proteins, Euthanasia, Humans, Neoplasms, Inflammatory Bowel Diseases, Gene Expression Regulation, Neoplastic, Mice, Knockout, Interleukin-18, Tumor Burden, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.